MedPath

Geriatric Assessment Reporting in Real Time (GARRT) in Non-electively Hospitalized Older Cancer Patients

Not Applicable
Completed
Conditions
Oncology
Interventions
Other: Results of the brief geriatric assessment
Other: No results of brief geriatric assessments
Registration Number
NCT03951090
Lead Sponsor
UNC Lineberger Comprehensive Cancer Center
Brief Summary

This study prospectively evaluates the impact of geriatric assessment reporting in real-time (GARRT) on key hospital based outcomes in a cohort of non-electively hospitalized older (\> 70 years) adults with cancer.

Detailed Description

This study evaluates the impact of geriatric assessment reporting in real-time (GARRT) on key hospital based outcomes in non-electively hospitalized older (\> 70 years) adults with cancer. Participants will be randomly assigned to the GARRT group, or the control group. All participants will fill out user friendly questionnaire called the geriatric assessment. The results of the geriatric assessment will be given to the physicians of participants in the GARRT group in real-time. The physicians of participants in the control group will not receive real time results.

This study will compare the referral rates of participants in each group to determine if providing real-time results of the geriatric assessment impact referral rates.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
148
Inclusion Criteria
  • Age 70 years or older.
  • English speaking.
  • Admitted to UNC Hospitals non-electively within 72 hours.
  • Biopsy proven solid tumor or myeloma or lymphoma.
  • Newly diagnosed cancer patients for whom active cancer directed therapy is planned within the next six months or patients on active cancer directed therapy either currently or within the previous 6 months.
  • Signed written IRB-approved informed consent.
Exclusion Criteria
  • Patients meeting any of the following exclusion criteria at baseline will be excluded from study participation. Patients with a life expectancy <6 weeks
  • Patients who are <48 hours post-surgery.
  • Patients who are admitted to an intensive care setting.
  • Patients with acute myeloma lymphoma (AML) or other high grade hematologic malignancies.
  • Patients undergoing bone marrow transplant or admitted to the bone marrow transplant unit.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
GARRT ArmResults of the brief geriatric assessmentParticipants in this arm complete an brief geriatric assessment, and the results of these assessments are given to providers with recommendations to address deficits identified by the geriatric assessment
Control ArmNo results of brief geriatric assessmentsProviders of participants of this group will not receive the results of the brief geriatric assessments. These participants will receive standard of care treatment
Primary Outcome Measures
NameTimeMethod
Referral rate for GA-identified deficits in intervention and control groups2 years

Number of participants with at least one referral for a GA-idenfied deficit

Secondary Outcome Measures
NameTimeMethod
Referral to Physical and Occupational therapy2 years

Number of times physical and occupation therapy referral was given in Intervention and Control group

Referral to Geriatic Consultation2 years

Number of times a Geriatric Consultation referral was given in Intervention and Control group

Referral to Clinical Pharmacist2 years

Number of times Clinical Pharmacist referral was given in Intervention and Control group

Referral to Nutritionist2 years

Number of times Nutritionist referral was given in Intervention and Control group

Referral to psyhcosocial support team2 years

Number of times psychosocial support referral was given in Intervention and Control group

Physician Reported New information2 years

Number of times physicians answer "yes" to the questions "did report provide new information about patient deficits that would warrant a referral"

Physician Reported Satisfaction2 years

Number of times physician indicate "yes" report was helpful when asked "Is this report useful"

Trial Locations

Locations (1)

UNC Lineberger Comprehensive Cancer Center

🇺🇸

Chapel Hill, North Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath